Preferred Name | ziprasidone | |
Synonyms |
5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one CP-88,059-01 CP 88059-01 CP-88,059-1 ziprazidone ziprasidone hydrochloride CP-88,059 Geodon CP 88059 ziprasidone hydrochloride, monohydrate |
|
ID |
http://purl.bioontology.org/ontology/MESH/C092292 |
|
altLabel |
5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one CP-88,059-01 CP 88059-01 CP-88,059-1 ziprazidone ziprasidone hydrochloride CP-88,059 Geodon CP 88059 ziprasidone hydrochloride, monohydrate |
|
cui |
C0939698 C0380393 C0380390 C0380391 C0380392 C0939539 |
|
HM |
D013844 D010879 |
|
Inverse of RB |
6UKA5VEJ6X 216X081ORU |
|
isa |
http://purl.bioontology.org/ontology/MESH/D012702 |
|
LT |
TRD |
|
Mapped to | ||
MDA |
19950329 |
|
MeSH Frequency |
994 |
|
MMR |
20171012 |
|
notation |
C092292 |
|
PA |
D018492 D012702 D014150 |
|
PI |
*SPIRO COMPOUNDS (95) |
|
prefLabel |
ziprasidone |
|
RR |
138982-67-9 (HCl monohydrate) 216X081ORU 146939-27-7 (ziprasidone) |
|
SC |
1 |
|
Scope Statement |
a benzisothiazoylpiperazine derivative; has combined dopamine and serotonin receptor antagonist activity; structurally related to tiospirone |
|
SRC |
Psychopharmacology (Berl) 1993;112(2-3):308-14 |
|
TERMUI |
T487796 T273639 T273641 T273637 T273644 T273643 T273640 T273642 T356879 T273638 T470485 |
|
TH |
NLM (2002) NLM (1995) FDA SRS (2013) NLM (2001) USAN (1994) USAN (19XX) INN (19XX) FDA SRS (2015) |
|
tui |
T109 T121 |